MedTrace Logo

Effect of Melatonin on Cardiovascular and Muscle Mass and Function in Patients With Heart Failure

NCT03894683 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-03-28

No results posted yet for this study

Summary

The main aim of this study is to investigate the effect of melatonin on clinical outcome, quality of life, and cardiovascular function of the patients with heart failure, as well as its effect on their skeletal muscle mass and function.

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

DRUG

Melatonin 10 mg

Melatonin tablets (10 mg)

DRUG

Placebo Oral Tablet

Placebo tablets manufactured the same as melatonin tablets

Sponsors & Collaborators

  • National Institute for Medical Research Development

    collaborator UNKNOWN

  • Isfahan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Masoumeh Sadeghi, MD · Cardiac Rehabilitation Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-30
Primary Completion
2020-05-31
Completion
2020-12-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03894683 on ClinicalTrials.gov